Abstract
Vernonia amygdalina, is a perennial tropical shrub from Asteraceae with a height ranging from 1 to 10 m tall. In Tropical African Countries, V. amygdalina, known as bitter leaf because of the bitter taste of the leaf, is propagated for consumption as a vegetable due to its medicinal properties. In this paper, the use of the plant V. amygdalina for the treatment of diabetes mellitus is reviewed by searching scientific databases such as Frontiers, HealthSTAR, MDPI, MEDLINE, Pubmed, Taylor and Francis, Science Direct, Scopus, Springer, Wiley, American Diabetes Association from 2000 to January 2021. Herbal medicine is a form of healthcare that has been used in diabetes treatment. One such herbal plant is V. amygdalina, a multipurpose plant with many uses, health benefits, and bioactivities. V. amygdalina is identified as the most medically beneficial plant in the genus Vernonia. V. amygdalina possesses several activities, including the anti-diabetic effect. This review discusses classifications and treatments (conventional and herbal) of diabetes mellitus, the phytochemical profile of V. amygdalina and its uses in the treatment of diabetes mellitus, and their mechanisms of action of the plant. The published literature used for the present work supports anti-diabetic properties of V. amygdalina.
Abstract from the paper’s OpenAlex record, shown for indexing and research. Copyright remains with the authors or the publisher. Read at the source ↗
The text the model read, with the source record’s inline markup (italics, sub- and superscripts) rendered and its character entities decoded; quote offsets refer to the raw text.
Claims 0
Judged off_topic: human health or diet — claims were not extracted. This is a scope decision by the model, not a statement about the paper’s findings.